美股市場個股詳情
CTLT Catalent(Delisted)
- 63.480
- 0.0000.00%
收盤價 12/17 16:00 (美東)
115.22億總市值-27.84市盈率TTM
0.000最高價0.000最低價0股成交量0.000今開63.480昨收0.00成交額0.00%換手率虧損市盈率(靜)1.82億總股本63.50052周最高3.25市淨率114.51億流通值42.11052周最低--股息TTM1.80億流通股142.640歷史最高--股息率TTM0.00%振幅18.920歷史最低--平均價1股每手
關於Catalent(Delisted)公司
康泰倫特是一個合同開發和製造組織，簡稱CDMO。它的業務分爲四個部分:生物製品；軟凝膠和口腔技術；口腔和專業交付以及臨牀供應服務。其收入主要來自與製藥客戶的長期供應協議。該公司在產品的整個生命週期(從藥物開發過程到商業供應)爲藥物、基於蛋白質的生物製劑、細胞和基因療法以及消費者健康產品提供一系列的開發和製造解決方案，在四大洲擁有50多家工廠。
公司介紹
公司代碼CTLT
公司名稱Catalent(Delisted)
發行價格20.50
CEOMr. Alessandro Maselli
所屬市場紐交所
員工數量16900
年結日06-30
董事高管
- 姓名
- 職務
- 年薪
- Alessandro Maselli
- Director, Chief Executive Officer and President
- 658.37萬
- Matti Masanovich
- Senior Vice President and Chief Financial Officer
- --
- Lisa Evoli
- Senior Vice President and Chief Human Resources Officer
- --
- Joseph A. Ferraro
- Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
- --
- Michael J. Hatzfeld, Jr
- Vice President and Chief Accounting Officer
- --
- Karen Murphy Santiago
- Vice President and Business Transformation & Integration Officer
- --
- Scott Gunther
- Senior Vice President, Quality and Regulatory Affairs
- --
- Dr. Aristippos Gennadios
- Group President, Pharma and Consumer Health
- 379.96萬
- David McErlane
- Group President, Biologics
- --
- John J. Greisch
- Executive Chairman of the Board
- 40.09萬
- Ricky Hopson
- President, Division Head of BioProduct Delivery and Chief of Staff
- 97.23萬
- J. Martin Carroll
- Independent Director
- 42.64萬
- Michelle R. Ryan
- Independent Director
- --
- Steven K. Barg
- Independent Director
- --
- Jack L. Stahl
- Lead Independent Director
- 39.51萬
- Gregory T. Lucier
- Independent Director
- 38.76萬
- Dr. Donald Eugene Morel, Jr
- Independent Director
- 38.50萬
- Michael J. Barber
- Independent Director
- 37.50萬
- Rolf A. Classon
- Independent Director
- 38.50萬
- Stephanie S. Okey, M.S.
- Independent Director
- --
- Frank D’Amelio
- Independent Director
- --
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據
